While COVID-19’s influence persists, we see renewed interest in sustainability and the evolving impact of Brexit’s export regulations, which will shape how the pharma and cold chain industries operate.
When selecting a supply chain partner, due diligence is critical. This article highlights questions you should be asking to ensure you are selecting the right supply chain partner for your clinical trial needs.
Since it is not possible to anticipate every possible transport route, a set of industry-recognized tests was selected to represent a challenging use scenario. The two main risks to frozen material during transport are mechanical and thermal. In this note we have evaluated the Celsius® FFT | FFTp Box Shipper and Celsius® FFT | FFTp Bulk Shipper using the ASTM D-4169 test for mechanical risks and the ISTA 7D test for thermal risks.
Just-in-time monitoring can offer companies a reliable, cost-effective means of tracking a shipment’s temperature fluctuations in transit, allowing for usable regulatory data that can inform subsequent shipping strategy.
For the industry to realize the potential of cell and gene therapies (CGTs), we must develop improved solutions that reliably support the control and transport of critical CGT raw materials and products.
As we continue to navigate 2021 and this year’s cold chain industry, we reflect on the events of 2020. Our three predictions all show how COVID-19’s influence persists, and in some instances, may have a long-term ripple effect.